Information about Skin Tech Pharma Group BNLX
My details
*
*
*
No warnings for this company
{{translate('company_activity_bron_' + bron)}}
Code Description
{{activiteit.code}} {{activiteit.description}}

Skin Tech Pharma Group BNLX (SRL)

64364305

Sitiopark 13, 3941 PP Doorn

Company information

Status
Active

KVK number

64364305

VAT Number

Established
15-10-2015
Last balance sheet year
2024
Company size
Small 0 FTE
RSIN number
855635228
Commercial name
Skin Tech Pharma Group België
Principal activity
Groothandel in medische en tandheelkundige instrumenten, verpleeg- en orthopedische artikelen en laboratoriumbenodigdheden
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Skin Tech Pharma Group BNLX

2024 2023 2022 2021
Equity € 380.926 -8 % € 413.919 -10 % € 458.306 -5 % € 480.627
Employees 0 1 1 0

Frequently asked questions

What is the VAT number of Skin Tech Pharma Group BNLX?
Log in or start a free trial to view the VAT number.
What is the KVK number of Skin Tech Pharma Group BNLX?
The KVK number of Skin Tech Pharma Group BNLX is 64364305
When was Skin Tech Pharma Group BNLX founded?
Skin Tech Pharma Group BNLX was founded on 15-10-2015.
What is the address of Skin Tech Pharma Group BNLX?
The current registered office of Skin Tech Pharma Group BNLX is located at Sitiopark 13, 3941 PP Doorn.
When was the last time Skin Tech Pharma Group BNLX filed their annual financial statements?
The most recent financial statements of Skin Tech Pharma Group BNLX were filed on 02-07-2025.
How many employees does Skin Tech Pharma Group BNLX have?
There are currently no employees working at Skin Tech Pharma Group BNLX or no workforce information is available.
What is the annual turnover of Skin Tech Pharma Group BNLX?
There is no turnover available for Skin Tech Pharma Group BNLX.

Sources